keyword
Keywords primary hyperparathyroidism gu...

primary hyperparathyroidism guidelines

https://read.qxmd.com/read/38551756/quality-appraisal-of-clinical-practice-guidelines-for-the-evaluation-and-management-of-primary-hyperparathyroidism
#1
JOURNAL ARTICLE
Mandy K Salmon, Christian G Fritz, Louis-Xavier Barrette, Dominic Romeo, Neeraj V Suresh, Jinggang J Ng, Eesha Balar, Aman Prasad, Alvaro Moreira, Karthik Rajasekaran
PURPOSE: Multiple groups have created clinical practice guidelines (CPGs) for the management of primary hyperparathyroidism (PHPT). This report provides a rigorous quality assessment using the Appraisal of Guidelines for Research & Evaluation Instrument (AGREE II) to identify high-performing guidelines and areas for improvement. METHODS: A systematic review was conducted to isolate CPGs addressing the management of PHPT. Guideline data was extracted and quality ratings were assigned by four independent reviewers...
March 29, 2024: Endocrine
https://read.qxmd.com/read/38459417/the-role-of-demographic-and-clinical-factors-in-germline-mutation-testing-for-patients-with-primary-hyperparathyroidism
#2
JOURNAL ARTICLE
Patrick T Hangge, Sophie Dream, Tina W F Yen, Kara Doffek, Samantha M Stachowiak, Joseph Shaker, Douglas B Evans, Tracy S Wang
INTRODUCTION: Guidelines recommending genetic counseling in primary hyperparathyroidism (PHPT) vary. To further delineate current recommendations, this study examined genetic counseling referral patterns and rates of mutations in surgical patients with PHPT. PATIENTS AND METHODS: A single-institution review was performed of adult patients who underwent parathyroidectomy for presumed sporadic PHPT. Genetic testing indications of hypercalcemia onset ≤ 40 years, multigland disease (MGD), family history (FHx) of PHPT, or other clinical indications suspicious for a PHPT-related endocrinopathy were examined by demographics and mutation detection rates...
March 8, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38452840/unveiling-the-hidden-stroke-threat-in-patients-with-atrial-fibrillation-and-primary-hyperparathyroidism
#3
JOURNAL ARTICLE
Georges Khattar, Samer Asmar, Elie Bou Sanayeh, Praneeth Keesari, Wissam Rahi, Fouad Sakr, Michel Khoury, Michael Cinelli, Samantha Lee, Mitchell Weinberg, Marcin Kowalski, Valay Parikh
Recent ACC/AHA/ACCP/HRS guidelines suggest that patients with Atrial fibrillation (AF) at intermediate to low annual risk of ischemic stroke can benefit from consideration of factors that might modify their risk of stroke. The role of non-traditional risk factors such as primary hyperparathyroidism (PHPT) remains unexplored. In our study, we investigated the potential association between PHPT and the risk of ischemic stroke among patients with AF. Using data from the Nationwide Inpatient Sample Database, a retrospective cohort study focused on the adult population with AF and stratified them based on PHPT presence...
March 5, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38449925/long-term-calcium-monitoring-post-parathyroidectomy-for-primary-hyperparathyroidism
#4
JOURNAL ARTICLE
William Jenkins, Edward Chisholm, Faith Protts
BACKGROUND:  Cure rates following parathyroidectomy for primary hyperparathyroidism are excellent, with well-documented low short-term recurrence rates of hypercalcaemia. Rates of long-term recurrence have been investigated to a lesser extent, but recent studies have reported higher than anticipated rates. This study sought to evaluate recurrence rates at more than four years post seemingly corrective surgery and depending on the findings, propose whether recommendations of annual calcium monitoring post-parathyroidectomy are appropriate based on the limited data available at the time of formulating guidelines...
February 2024: Curēus
https://read.qxmd.com/read/38343604/case-presentation-functional-assessment-of-a-casr-variant-identified-in-a-patient-with-hypercalcaemia-confirms-familial-hypocalciuric-hypercalcaemia-in-the-patient-and-a-sister-previously-misdiagnosed-with-primary-hyperparathyroidism
#5
Bryan K Ward, Kirsten A Loffell, John P Walsh, Warwick D Howe, Suzanne J Brown, Scott G Wilson
BACKGROUND: Primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH) are common causes of hypercalcaemia. Patients are mostly asymptomatic in the case of FHH and often so in the case of PHPT. In addition, biochemical parameters show considerable overlap, making differential diagnosis difficult. Genetic screening for inactivating variants in the calcium-sensing receptor ( CASR ) gene that are causative of FHH assists with the diagnosis since such variants are not generally associated with PHPT...
2024: Case Reports in Endocrinology
https://read.qxmd.com/read/38339246/does-genotype-specific-phenotype-in-patients-with-multiple-endocrine-neoplasia-type-2-occur-as-current-guidelines-predict
#6
JOURNAL ARTICLE
Teresa Binter, Sabina Baumgartner-Parzer, Marie Helene Schernthaner-Reiter, Melisa Arikan, Lindsay Hargitai, Martin Bruno Niederle, Bruno Niederle, Christian Scheuba, Philipp Riss
The clinical manifestation of multiple endocrine neoplasia type 2 (MEN2) in terms of developing medullary thyroid cancer (MTC), pheochromocytoma (PCC), and/or primary hyperparathyroidism (PHPT) is related to the respective pathogenic variant of the RET proto-oncogene. The aim of this study is to retrospectively analyze the individual, genotype-dependent clinical manifestations of a large cohort of MEN2 patients. By comparing their clinical profile with currently existing evidence-based knowledge, an optimal therapy and prevention strategy in terms of prophylactic thyroidectomy and clinical follow-up could be ensured...
January 24, 2024: Cancers
https://read.qxmd.com/read/38325011/modern-trends-for-primary-hyperparathyroidism-intervening-on-less-biochemically-severe-disease
#7
JOURNAL ARTICLE
Lauren N Krumeich, Angelica Santos, Douglas L Fraker, Rachel R Kelz, Heather Wachtel
INTRODUCTION: Primary hyperparathyroidism (PHPT) is defined by autonomous parathyroid hormone secretion, which has broad physiologic effects. Parathyroidectomy is the only cure and is recommended for patients demonstrating symptomatic disease and/or end organ damage. However, there may be a benefit to intervening before the development of complications. We sought to characterize institutional trends in the biochemical and symptomatic presentation of PHPT and the associated cure and complication rates...
February 6, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38223338/real-world-usage-of-chronic-kidney-disease-mineral-bone-disorder-ckd-mbd-biomarkers-in-nephrology-practices
#8
JOURNAL ARTICLE
Maria Fusaro, Simona Barbuto, Maurizio Gallieni, Althea Cossettini, Giulia Vanessa Re Sartò, Laura Cosmai, Giuseppe Cianciolo, Gaetano La Manna, Thomas Nickolas, Serge Ferrari, Jordi Bover, Mathias Haarhaus, Carmela Marino, Maria Cristina Mereu, Maura Ravera, Mario Plebani, Martina Zaninotto, Mario Cozzolino, Stefano Bianchi, Piergiorgio Messa, Mariacristina Gregorini, Lorenzo Gasperoni, Caterina Agosto, Andrea Aghi, Giovanni Tripepi
BACKGROUND: Chronic kidney disease mineral bone disorder (CKD-MBD) is a condition characterized by alterations of calcium, phosphate, parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF-23) metabolism that in turn promote bone disorders, vascular calcifications, and increase cardiovascular (CV) risk. Nephrologists' awareness of diagnostic, prognostic, and therapeutic tools to manage CKD-MBD plays a primary role in adequately preventing and managing this condition in clinical practice...
January 2024: Clinical Kidney Journal
https://read.qxmd.com/read/38202152/the-nexus-of-hyperparathyroidism-and-thyroid-carcinoma-insights-into-pathogenesis-and-diagnostic-challenges-a-narrative-review
#9
REVIEW
Gregorio Scerrino, Nunzia Cinzia Paladino, Giuseppina Orlando, Giuseppe Salamone, Pierina Richiusa, Stefano Radellini, Giuseppina Melfa, Giuseppa Graceffa
This review investigates the intricate relationship between hyperparathyroidism (HPT) and thyroid carcinoma (TC), aiming to elucidate their coexistence, potential pathogenetic mechanisms, and clinical implications. A systematic search strategy, employing the MeSH terms 'Hyperparathyroidism' and 'Thyroid Carcinoma', spanned publications from 2013 to 2023 across the PubMed, Web of Science, and Scopus databases. Fifteen selected articles were analyzed. Studies unanimously confirm the notable association between primary hyperparathyroidism (PHPT) and thyroid nodules/cancer, with incidences ranging from 2...
December 27, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38192532/utility-of-99mtc-sestamibi-single-photon-emission-computed-tomography-spect-ct-single-imaging-strategy-in-the-preoperative-localization-of-parathyroid-adenoma
#10
JOURNAL ARTICLE
Nikhil Vasandani
Background Primary hyperparathyroidism is an endocrinopathy associated with dysregulated calcium homeostasis. The most common etiology is a parathyroid adenoma most definitely managed via a parathyroidectomy. The two main surgical approaches include a minimally invasive parathyroidectomy (MIP) and open four-gland exploration (4-GE). MIP is the preferred operative strategy since it is associated with less postoperative complications. Accurate preoperative imaging is essential in informing the optimal approach to surgery...
January 2024: Curēus
https://read.qxmd.com/read/38151705/treating-intra-thyroid-parathyroid-adenoma-by-radiofrequency-is-a-valuable-alternative-to-hemithyroidectomy
#11
JOURNAL ARTICLE
Andrea Leoncini, Maurilio Deandrea, Francesca Retta, Pierpaolo Trimboli
BACKGROUND: Parathyroid adenoma (PA) is the most common cause of primary hyperparathyroidism (PHPT). One infrequent scenario (0.7%-6%) is represented by intra-thyroid PA (I-PA), an ectopic variant of the parathyroid gland included in the thyroid parenchyma. Radiofrequency (RF) of I-PA seems to be an excellent alternative to hemithyroidectomy for these patients. The present study aimed to report three cases of PHPT and I-PA treated with RF at two institutions. MATERIALS AND METHODS: These two institutions share guidelines for thyroid RF...
2023: International Journal of Hyperthermia
https://read.qxmd.com/read/37918992/2022-recommendations-of-the-afu-lithiasis-committee-medical-management%C3%A2-%C3%A2-from-diagnosis-to-treatment
#12
REVIEW
S Lemoine, P Dahan, J P Haymann, P Meria, C Almeras
The morphological-compositional analysis of urinary stones allows distinguishing schematically several situations: dietary, digestive, metabolic/hormonal, infectious and genetic problems. Blood and urine testing are recommended in the first instance to identify risk factors of urinary stone disease in order to avoid recurrence or progression. The other objective is to detect a potential underlying pathology associated with high risk of urinary stone disease (e.g. primary hyperparathyroidism, primary or enteric hyperoxaluria, cystinuria, distal renal tubular acidosis) that may require specific management...
November 2023: Progrès en Urologie
https://read.qxmd.com/read/37873505/older-patients-with-asymptomatic-primary-hyperparathyroidism-should-criteria-for-surgery-be-expanded
#13
JOURNAL ARTICLE
Marisa A Bartz-Kurycki, Sophie Dream, Tina W Yen, Kara Doffek, Joseph Shaker, Douglas B Evans, Tracy S Wang
CONTEXT: Patients with primary hyperparathyroidism (PHPT) can present with variable signs, symptoms, and end-organ effects. Clinical practice guidelines influence referral for consideration of parathyroidectomy. OBJECTIVE: This study compared the demographic, biochemical, and symptom profile and examine indications for surgery in patients older than 50 years who underwent parathyroidectomy to determine how changes to current guidelines may affect recommendations for parathyroidectomy...
August 2, 2023: Journal of the Endocrine Society
https://read.qxmd.com/read/37779800/incidental-normocalcemic-primary-hyperparathyroidism-presenting-with-symptomatic-hypophosphatemia-a-case-report
#14
Omar Tabbikha, Joanne Chamy, Michael El Khoury
Normocalcemic primary hyperparathyroidism (NHPT) is a newly defined variant of primary hyperparathyroidism (PHPT). It's defined by consistently normal total and ionised calcium levels with elevated parathyroid hormone in the absence of secondary causes of hyperparathyroidism in at least three consecutive times over a period of three to six months. Consensus whether the same criteria used to recommend surgery in PHPT should be used to recommend surgery in NHPT is still lacking. Even though PHPT is known to cause hypophosphatemia, serum phosphate is not relevant when diagnosing it or NHPT...
August 2023: Curēus
https://read.qxmd.com/read/37745146/primary-hyperparathyroidism-clinical-manifestations-diagnosis-and-evaluation-according-to-the-fifth-international-workshop-guidelines
#15
REVIEW
Magdalena Kochman
Primary hyperparathyroidism (PHPT) is a frequent endocrine disease which mainly affects the skeletal system and kidney. Some of its signs and symptoms are similar to those seen in rheumatic diseases such as rheumatoid arthritis, Sjögren's disease, fibromyalgia, polymyalgia rheumatica, gout or systemic lupus erythematosus. Coexistence of primary hyperparathyroidism with those pathologies potentiate their effects on muscles, bones and joints, increasing the risk of complications such as osteoporosis and fractures...
2023: Reumatologia
https://read.qxmd.com/read/37661450/a-japanese-family-meeting-the-clinical-diagnostic-criteria-for-men1-with-a-men1-variant-of-uncertain-significance
#16
JOURNAL ARTICLE
Hiroyuki Matsubayashi, Yoshimi Kiyozumi, Rina Harada, Takashi Mukaigawa, Teichi Sugiura, Hirotoshi Ishiwatari, Junya Sato, Fumitaka Niiya, Kazuaki Nakashima, Nobuhiro Kado, Seiichiro Nishimura, Goichi Honda, Nobuyuki Ohike
Multiple gastroenteric, pancreatic, and pituitary neuroendocrine neoplasms (NENs) were diagnosed in a 74-year-old man with a history of primary hyperparathyroidism (PHPT). Germline testing demonstrated a variant of MEN1 (c.1694T>A, p.L565Q), whose pathogenicity was classified as a variant of uncertain significance (VUS) according to the ACMG/AMP guidelines. The same germline variant was detected in the patient's son and daughter, who also showed PHPT or hypercalcemia and met the clinical diagnostic criteria for multiple endocrine neoplasia Type 1 (MEN1)...
September 1, 2023: Internal Medicine
https://read.qxmd.com/read/37554877/giant-parathyroid-adenoma-causing-severe-hypercalcemia-a-case-report-from-duhok
#17
JOURNAL ARTICLE
Dildar Haji Musa, Azri Salih Haji Sgery, Asaad Shareef Omar, Gina James Keorges, Nashwan Mr Ibrahim
UNLABELLED: Nephrolithiasis, a common urological disease, could indicate a more ominous pathology beyond the kidneys. Patients who present with renal stones must be investigated for serum calcium and subsequently parathyroid hormones, if indicated, as one of the clinical presentations of primary hyperparathyroidism is renal stones. CASE PRESENTATION: A 48-year-old married female with a past medical history significant for renal stones presented to the clinic chiefly complaining of muscle pain, joint pain, and fatigue...
August 2023: Annals of Medicine and Surgery
https://read.qxmd.com/read/37509698/neuroendocrine-parathyroid-tumors-quality-of-life-in-patients-with-primary-hyperparathyroidism
#18
REVIEW
Mara Carsote, Claudiu Nistor, Mihaela Stanciu, Florina Ligia Popa, Remus Calin Cipaian, Ovidiu Popa-Velea
Tumors of the parathyroid glands, when associated with PTH (parathyroid hormone) excess, display a large area of complications; in addition to the classical clinical picture of primary hyperparathyroidism (PHP), a complex panel of other symptoms/signs can be identified, including memory and cognitive impairment, chronic asthenia/fatigue, reduced muscle functionality, depressive mood, non-specific bone pain, and loss of sleep quality. The perception of quality of life (QoL) can be supplementarily enhanced by their progressive onset, which makes many patients not be fully aware of them...
July 21, 2023: Biomedicines
https://read.qxmd.com/read/37497203/clinical-characteristics-and-management-of-patients-with-secondary-hyperparathyroidism-undergoing-hemodialysis-a-feasibility-analysis-of-electronic-health-records-using-natural-language-processing
#19
JOURNAL ARTICLE
Alberto Ortiz, Jose Portoles, Maria Dolores Pino-Pino, Jesús Barea, María López, Patricia de Sequera, Borja Quiroga, Rocio Echarri, Mario Prieto Velasco, Rafael Díaz, Gonzalo Gómez Marqués, Pilar Sanchez Perez, Vicens Torregrosa, Mariano Rodriguez
INTRODUCTION: This study aimed to assess the feasibility of applying natural language processing (NLP) to analyze real-world data (RWD) and resolve clinical problems in patients with secondary hyperparathyroidism and chronic kidney disease undergoing hemodialysis (SHPT/CKD-HD). The primary objective was to evaluate how well the guideline-recommended analytical goals are achieved in a Spanish cohort of SHPT/CKD-HD patients based on RWD. METHODS: Unstructured data in the electronic health records (EHRs) from 8 hospitals were retrospectively analyzed using the EHRead ® technology, based on NLP and machine learning...
May 2023: Kidney Diseases
https://read.qxmd.com/read/37409183/prevalence-of-endocrine-manifestations-and-gist-in-108-systematically-screened-patients-with-neurofibromatosis-type-1
#20
JOURNAL ARTICLE
Hippolyte Dupuis, Benjamin Chevalier, Catherine Cardot-Bauters, Arnaud Jannin, Christine Do Cao, Miriam Ladsous, Christine Cortet, Emilie Merlen, Magali Drouard, Sébastien Aubert, Dominique Vidaud, Stéphanie Espiard, Marie-Christine Vantyghem
CONTEXT: In patients with neurofibromatosis type 1 (NF1), guidelines suggest screening for pheochromocytoma by metanephrine measurement and abdominal imaging, which may lead to the discovery of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and their differential diagnosis, gastrointestinal stromal tumors (GISTs). Other endocrine manifestations such as follicular thyroid carcinoma and primary hyperparathyroidism have also been reported in a few cases. OBJECTIVE: This study aimed to describe prevalence and clinical presentation of these manifestations through systematic screening in a large cohort of patients...
July 3, 2023: Journal of the Endocrine Society
keyword
keyword
96228
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.